Latest Articles

Publication Date
Acrivon narrows focus for ACR-368 in endometrial cancer - BioWorld Online

Acrivon narrows focus for ACR-368 in endometrial cancer BioWorld Online

Published: March 27, 2025, 3 p.m.
Endometrial cancer patients to receive funded immunotherapy - Hong Kong Standard

Endometrial cancer patients to receive funded immunotherapy Hong Kong Standard

Published: March 27, 2025, 9:09 a.m.
SIRT7 facilitates endometrial cancer progression by regulating PTEN stability in an estrogen-dependent manner - Nature.com

SIRT7 facilitates endometrial cancer progression by regulating PTEN stability in an estrogen-dependent manner Nature.com

Published: March 27, 2025, 6:35 a.m.
Ferroptosis in Endometriosis: Traditional Chinese Medicine Interventions and Mechanistic Insights.

Endometriosis (EMS) is a chronic, estrogen-dependent inflammatory disease affecting 5-10% of women of reproductive age, characterized by the growth of endometrial tissue on the outside of the uterus. The dysregulation …

Published: March 27, 2025, midnight
Association of composite dietary antioxidant index and endometriosis risk in reproductive-age women: a cross-sectional study using big data-machine learning approach.

Endometriosis (EM) is a chronic gynecological disorder characterized by the growth of endometrial-like tissue outside the uterus, leading to pain and infertility. Recent studies suggest that antioxidants may play a …

Published: March 27, 2025, midnight
Dr Mirza on Long-Term Response Data for Dostarlimab Plus Chemo in Advanced Endometrial Cancer - OncLive

Dr Mirza on Long-Term Response Data for Dostarlimab Plus Chemo in Advanced Endometrial Cancer OncLive

Published: March 26, 2025, 10:21 p.m.
Humacyte to raise $50M; Acrivon to focus on prexasertib in endometrial cancer - Endpoints News

Humacyte to raise $50M; Acrivon to focus on prexasertib in endometrial cancer Endpoints News

Published: March 26, 2025, 2:10 p.m.
Acrivon stops developing Lilly castoff for ovarian and bladder cancers to switch focus to endometrial - Fierce Biotech

Acrivon stops developing Lilly castoff for ovarian and bladder cancers to switch focus to endometrial Fierce Biotech

Published: March 26, 2025, 11:05 a.m.
Promising Phase 2 Results for ACR-368 in Endometrial Cancer Justify Buy Rating - TipRanks

Promising Phase 2 Results for ACR-368 in Endometrial Cancer Justify Buy Rating TipRanks

Published: March 26, 2025, 10:20 a.m.
Immunopathology of Endometriosis, Molecular Approaches.

Endometriosis (EMS) is a common chronic gynecological disorder affecting 5%-10% of reproductive-age women, often causing infertility, dyspareunia, pain, and limitations in physical and sexual activities. This condition is defined by …

Published: March 26, 2025, midnight
Link copied to clipboard!
Subscribe to Our Newsletter

Stay updated with our latest articles!